GALASSI, ANDREA
GALASSI, ANDREA
Universita' degli Studi di MILANO
Abnormal variations in the facial soft tissues of adult uremic patients on chronic dialysis
2005 V. F. Ferrario, C. Sforza, C. Dellavia, A. Galassi, D. Brancaccio
Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification
2009 D. Brancaccio, A. Bellasi, M. Cozzolino, A. Galassi, M. Gallieni
Awareness of hypertension and proteinuria in randomly selected patients in 11 Italian cities. A 2005 report of the National Kidney Foundation of Italy
2009 A. Galassi, D. Brancaccio, M. Cozzolino, G. Bellinghieri, U. Buoncristiani, F. Cavatorta, L. D'Apice, B. Di Iorio, L. Gesualdo, S. Gianni, B. Ricciardi, D. Russo, V. Andreucci
Cardiac valve calcification : an immutable pathologic finding in chronic kidney disease?
2013 A. Bellasi, A. Galassi, S. Papagni, M. Cozzolino
Cardiovascular disease in dialysis patients
2018 M. Cozzolino, M. Mangano, A. Stucchi, P. Ciceri, F. Conte, A. Galassi
Chelanti del fosforo a base di ferro : quali nuovi vantaggi? = Iron-based Phosphate Binders for ESRD Patients
2016 M. Cozzolino, M. Mangano, L. Magagnoli, L. Di Lullo, A. Galassi, D. Brancaccio, A. Bellasi
Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD), coinvolgimento cardiovascolare e prognosi
2017 A. Bellasi, M. Mangano, A. Galassi, M. Cozzolino
Cinacalcet, paricalcitol, or both?
2007 M. Cozzolino, A. Galassi, D. Brancaccio
Clinical significance of FGF-23 measurement in dialysis patients
2011 F. Jongbloed, A. Galassi, M. Cozzolino, R. Zietse, G. Chiarelli, D. Cusi, D. Brancaccio, M. Gallieni
Decreased serum fetuin-A levels after a single haemodialysis session
2007 M. Cozzolino, A. Galassi, M.L. Biondi, A. Butti, M. Russo, C. Longhini, M. Gallieni, D. Brancaccio
Facial changes in adult uremic patients on chronic dialysis: possible role of hyperparathyroidism
2005 V. F. Ferrario, C. Sforza, C. Dellavia, A. Galassi, L. Rocca Rey, G. Chiarelli, M. Cozzolino, M. Gallieni, D. Brancaccio
Impaired brachial artery endothelial flow-mediated dilation and orthostatic stress in hemodialysis patients
2008 M.A. Gallieni, A. Butti, M. Guazzi, A. Galassi, M.G. Cozzolino, D. Brancaccio
Magnesium : a renewed player of vascular ageing in diabetic CKD patients?
2014 A. Galassi, M. Cozzolino
Matrix GLA protein gene polymorphisms : clinical correlates and cardiovascular mortality in chronic kidney disease patients
2005 D. Brancaccio, M.L. Biondi, M. Gallieni, O. Turri, A. Galassi, F. Cecchini, D. Russo, V. Andreucci, M. Cozzolino
Mechanism of uremic osteodystrophy and prevention of hyperparathyroidism in the uremic patient
2003 D. Brancaccio, M. Cozzolino, A. Galassi, A. Bellasi, P. Carpani, M. Gallieni
Nuove acquisizioni nella patogenesi dell'iperparatiroidismo secondario = New insights in the pathogenesis of secondary hyperparathyroidism
2005 M. Cozzolino, A. Butti, G. Chiarelli, L. Rocca-Rey, A. Bellasi, A. Galassi, M. Gallieni, D. Brancaccio
Osteoporosis, bone mineral density and CKD-MBD: treatment considerations
2017 J. Bover, L. Bailone, V. López Báez, S. Benito, P. Ciceri, A. Galassi, M. Cozzolino
Paricalcitol and Cardiorenal Outcome : From the IMPACT Study to Clinical Practice
2013 A. Bellasi, A. Galassi, P. Salvi, M. Cozzolino
Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients : the role of paricalcitol
2008 M.G. Cozzolino, A. Galassi, M.A. Gallieni, D. Brancaccio
Pathogenesis of parathyroid hyperplasia in renal failure
2005 M. Cozzolino, D. Brancaccio, M. Gallieni, A. Galassi, E. Slatopolsky, A. Dusso